Adolescent Oligomenorrhea (Age 14-19) Tracks Into the Third Decade of Life (Age 20-28) and Predicts Increased Cardiovascular Risk Factors and Metabolic Syndrome

被引:25
作者
Glueck, Charles J. [1 ]
Woo, Jessica G. [2 ]
Khoury, Philip R. [2 ]
Morrison, John A. [2 ]
Daniels, Stephen R. [3 ]
Wang, Ping [1 ]
机构
[1] Jewish Hosp Cincinnati, Cholesterol Metab Thrombosis Ctr, Cincinnati, OH 45207 USA
[2] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Div Biostat Epidemiol, Cincinnati, OH 45229 USA
[3] Childrens Hosp, Denver, CO 80218 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2015年 / 64卷 / 04期
关键词
Metabolic syndrome; Oligomenorrhea; Polycystic ovary syndrome; Impaired fasting glucose-type 2 diabetes mellitus; POLYCYSTIC-OVARY-SYNDROME; NUTRITION EXAMINATION SURVEY; TYPE-2; DIABETES-MELLITUS; IMPAIRED GLUCOSE-TOLERANCE; IRREGULAR MENSTRUAL CYCLES; HORMONE-BINDING GLOBULIN; CLASS-III OBESITY; INSULIN-RESISTANCE; NATIONAL-HEALTH; CHILDHOOD INSULIN;
D O I
10.1016/j.metabol.2015.01.005
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective. Assess whether adolescent oligomenorrhea (age 14-19) tracks into young adulthood (age 20-28) and predicts increased cardiometabolic risk factors, metabolic syndrome (MetS), and impaired fasting glucose-type II diabetes mellitus (IFG + T2DM). Materials and methods. Prospective study of menstrual cyclicity and its metabolic effects in 865 black and white schoolgirls from age 9 to 19, and 605 of these 865 girls from age 20 to 28. Main findings. Patterns of menstrual delays (oligomenorrhea) during ages 14-19 and ages 20-28 were closely related (p <.0001). Adolescent menses delay (ages 14-19, p <.0001), mean insulin (ages 20-28, p =.0003), and self-identified polycystic ovary syndrome (PCOS, p =.049) predicted ages 20-28 menses delay. Menses delays during ages 14-19 and 20-28, and, their interaction product were correlated with IFG + T2DM and MetS at ages 20-28. Waist circumference (ages 20-28, p <.0001), mean triglyceride (ages 20-28, p =.005), and the number of average menstrual cycles >= 42 days (ages 20-28, p =.04) predicted IFG + T2DM (ages 20-28). MetS (ages 9-19, p <.0001), mean insulin (ages 20-28, p =.0002), the number of 242 day gaps between menstrual periods (ages 20-28, p =.02), and cigarette smoking at age 18-19 (p =.04) were significant explanatory variables for MetS at ages 27-28. As MetS status category changed from age 14-19 to 27-28 from best to worst: (no -> no), (yes -> no), (yes -> yes), (no -> yes), the number of women with >= 2 menses delays during ages 20-28 rose from 3% to 4% to 15% to 17%, p =.0001. MetS status change from age 9-19 to 27-28 was positively associated with mean insulin (age 20-28, p <.0001), cigarette smoking (age 24-25, p =.01) and the number of menses delays during ages 20-28 (p =.04). Principal conclusions. Menstrual patterns track from adolescence to young adulthood, and oligomenorrhea predicts MetS and IFG + T2DM. Patterns of menses delays in adolescence should be considered as a significant risk factor for future development of young adult IFG + T2DM, MetS, oligomenorrhea, and polycystic ovary syndrome. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:539 / 553
页数:15
相关论文
共 59 条
[1]
Relative weight and race influence average age at menarche: Results from two nationally representative surveys of US girls studied 25 years apart [J].
Anderson, SE ;
Dallal, GE ;
Must, A .
PEDIATRICS, 2003, 111 (04) :844-850
[2]
[Anonymous], 1986, J Adolesc Health Care, V7, P236
[3]
Reproductive factors, metabolic factors, and coronary artery calcification in older women [J].
Atsma, Femke ;
Bartelink, Marie-Louise E. L. ;
Grobbee, Diederick E. ;
Rutten, Annemarieke ;
Bots, Michiel L. ;
Prokop, Matthias ;
van der Schouw, Yvonne T. .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (05) :899-904
[4]
Chan Symphorosa S. C., 2009, Hong Kong Medical Journal, V15, P18
[5]
Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study [J].
Chang, Alice Y. ;
Ayers, Colby ;
Minhajuddin, Abu ;
Jain, Tulika ;
Nurenberg, Pamela ;
de Lemos, James A. ;
Wild, Robert A. ;
Auchus, Richard J. .
CLINICAL ENDOCRINOLOGY, 2011, 74 (01) :89-96
[6]
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25
[7]
Menstrual dysfunction in rural young women and the presence of polycystic ovarian syndrome [J].
Chhabra, S. ;
Venkatraman, S. .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2010, 30 (01) :41-45
[8]
LENGTH AND VARIABILITY OF HUMAN MENSTRUAL CYCLE [J].
CHIAZZE, L ;
BRAYER, FT ;
MACISCO, JJ ;
PARKER, MP ;
DUFFY, BJ .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1968, 203 (06) :377-&
[9]
Chung P. W., 2011, Hong Kong Medical Journal, V17, P391
[10]
Prevalence of a metabolic syndrome phenotype in adolescents - Findings from the Third National Health and Nutrition Examination Survey, 1988-1994 [J].
Cook, S ;
Weitzman, M ;
Auinger, P ;
Nguyen, M ;
Dietz, WH .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2003, 157 (08) :821-827